{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:15:41Z","timestamp":1791080141245,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hyperlipidemia plays a crucial role in the development and progression of coronary artery disease (CAD). Recent studies have identified that microRNAs (miRNAs) are important regulators of lipid metabolism, but little is known about the circulating levels of lipometabolism-related miRNAs and their relationship with the presence of CAD in patients with hyperlipidemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In the present study, we enrolled a total of 255 hyperlipidemia patients with or without CAD and 100 controls with normal blood lipids. The plasma levels of four known lipometabolism-related miRNAs, miR-122, miR-370, miR-33a, and miR-33b were quantified by real-time quantitative PCR. Blood levels of total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and high density lipoprotein cholesterol were determined. Furthermore, the severity of CAD was assessed with the Gensini score system based on the degree of luminal narrowing and its geographic importance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our results revealed for the first time that plasma levels of miR-122 and miR-370 were significantly increased in hyperlipidemia patients compared with controls, and the levels of miR-122 and miR-370 were positively correlated with TC, TG, and LDL-C levels in both hyperlipidemia patients and controls. Multiple logistic regression analysis demonstrated that the increased levels of miR-122 and miR-370 were associated with CAD presence, even after adjustment for other cardiovascular risk factors. Furthermore, miR-122 and miR-370 levels were positively correlated with the severity of CAD quantified by the Gensini score. However, both miR-33a and miR-33b were undetectable in plasma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results suggest that increased plasma levels of miR-122 and miR-370 might be associated with the presence as well as the severity of CAD in hyperlipidemia patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-511x-11-55","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T11:29:46Z","timestamp":1337081386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":165,"title":["Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease"],"prefix":"10.1186","volume":"11","author":[{"given":"Wei","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Mu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qing","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Guo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,15]]},"reference":[{"issue":"16","key":"710_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005, 352 (16): 1685-1695.","journal-title":"N Engl J Med"},{"key":"710_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.med.56.082103.104751","volume":"56","author":"DE Moller","year":"2005","unstructured":"Moller DE, Kaufman KD: Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med. 2005, 56: 45-62.","journal-title":"Annu Rev Med"},{"issue":"2","key":"710_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116 (2): 281-297.","journal-title":"Cell"},{"issue":"2","key":"710_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/MOL.0b013e3283428d9d","volume":"22","author":"C Fernandez-Hernando","year":"2011","unstructured":"Fernandez-Hernando C, Suarez Y, Rayner KJ, Moore KJ: MicroRNAs in lipid metabolism. Curr Opin Lipidol. 2011, 22 (2): 86-92.","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"710_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","volume":"3","author":"C Esau","year":"2006","unstructured":"Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3 (2): 87-98.","journal-title":"Cell Metab"},{"issue":"7068","key":"710_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Krutzfeldt","year":"2005","unstructured":"Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M: Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature. 2005, 438 (7068): 685-689.","journal-title":"Nature"},{"issue":"7189","key":"710_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nature06783","volume":"452","author":"J Elmen","year":"2008","unstructured":"Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U: LNA-mediated microRNA silencing in non-human primates. Nature. 2008, 452 (7189): 896-899.","journal-title":"Nature"},{"issue":"5962","key":"710_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1178178","volume":"327","author":"RE Lanford","year":"2010","unstructured":"Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010, 327 (5962): 198-201.","journal-title":"Science"},{"issue":"6","key":"710_CR9","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1194\/jlr.M004812","volume":"51","author":"D Iliopoulos","year":"2010","unstructured":"Iliopoulos D, Drosatos K, Hiyama Y, Goldberg IJ, Zannis VI: MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res. 2010, 51 (6): 1513-1523.","journal-title":"J Lipid Res"},{"issue":"5985","key":"710_CR10","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.1189862","volume":"328","author":"KJ Rayner","year":"2010","unstructured":"Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C: MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010, 328 (5985): 1570-1573.","journal-title":"Science"},{"issue":"27","key":"710_CR11","doi-asserted-by":"publisher","first-page":"12228","DOI":"10.1073\/pnas.1005191107","volume":"107","author":"TJ Marquart","year":"2010","unstructured":"Marquart TJ, Allen RM, Ory DS, Baldan A: miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A. 2010, 107 (27): 12228-12232.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5985","key":"710_CR12","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1126\/science.1189123","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","unstructured":"Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Naar AM: MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 2010, 328 (5985): 1566-1569.","journal-title":"Science"},{"issue":"40","key":"710_CR13","doi-asserted-by":"publisher","first-page":"17321","DOI":"10.1073\/pnas.1008499107","volume":"107","author":"T Horie","year":"2010","unstructured":"Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y: MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci U S A. 2010, 107 (40): 17321-17326.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"710_CR14","doi-asserted-by":"publisher","first-page":"33652","DOI":"10.1074\/jbc.M110.152090","volume":"285","author":"I Gerin","year":"2010","unstructured":"Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF, Leclercq IA, MacDougald OA, Bommer GT: Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem. 2010, 285 (44): 33652-33661.","journal-title":"J Biol Chem"},{"issue":"11","key":"710_CR15","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1161\/ATVBAHA.111.226696","volume":"31","author":"S Fichtlscherer","year":"2011","unstructured":"Fichtlscherer S, Zeiher AM, Dimmeler S: Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?. Arterioscler Thromb Vasc Biol. 2011, 31 (11): 2383-2390.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"710_CR16","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","volume":"110","author":"EE Creemers","year":"2012","unstructured":"Creemers EE, Tijsen AJ, Pinto YM: Circulating MicroRNAs: Novel Biomarkers and Extracellular Communicators in Cardiovascular Disease?. Circ Res. 2012, 110 (3): 483-495.","journal-title":"Circ Res"},{"issue":"3","key":"710_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/STROKEAHA.109.563502","volume":"41","author":"J Jimenez-Conde","year":"2010","unstructured":"Jimenez-Conde J, Biffi A, Rahman R, Kanakis A, Butler C, Sonni S, Massasa E, Cloonan L, Gilson A, Capozzo K: Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke. Stroke. 2010, 41 (3): 437-442.","journal-title":"Stroke"},{"issue":"4","key":"710_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF02364624","volume":"16","author":"WP Santamore","year":"1988","unstructured":"Santamore WP, Kahl FR, Kutcher MA, Negin M, Whiteman JL, Kase JP, Little WC: A microcomputer based automated, quantitative coronary angiographic analysis system. Ann Biomed Eng. 1988, 16 (4): 367-377.","journal-title":"Ann Biomed Eng"},{"issue":"3","key":"710_CR19","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","volume":"51","author":"GG Gensini","year":"1983","unstructured":"Gensini GG: A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983, 51 (3): 606-","journal-title":"Am J Cardiol"},{"issue":"2","key":"710_CR20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1194\/jlr.M700399-JLR200","volume":"49","author":"NP Tang","year":"2008","unstructured":"Tang NP, Wang LS, Yang L, Zhou B, Gu HJ, Sun QM, Cong RH, Zhu HJ, Wang B: Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population. J Lipid Res. 2008, 49 (2): 369-375.","journal-title":"J Lipid Res"},{"issue":"30","key":"710_CR21","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O\u2019Briant KC, Allen A: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008, 105 (30): 10513-10518.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"710_CR22","first-page":"136","volume":"60","author":"S Cirera","year":"2010","unstructured":"Cirera S, Birck M, Busk PK, Fredholm M: Expression profiles of miRNA-122 and its target CAT1 in minipigs (Sus scrofa) fed a high-cholesterol diet. Comp Med. 2010, 60 (2): 136-141.","journal-title":"Comp Med"},{"issue":"43","key":"710_CR23","doi-asserted-by":"publisher","first-page":"29514","DOI":"10.1074\/jbc.M109.027896","volume":"284","author":"S Dong","year":"2009","unstructured":"Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES, Zhang C: MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem. 2009, 284 (43): 29514-29525.","journal-title":"J Biol Chem"},{"issue":"22","key":"710_CR24","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1093\/eurheartj\/ehq167","volume":"31","author":"Y D\u2019Alessandra","year":"2010","unstructured":"D\u2019Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M: Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010, 31 (22): 2765-2773.","journal-title":"Eur Heart J"},{"issue":"3","key":"710_CR25","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bbrc.2010.03.075","volume":"394","author":"M Hoekstra","year":"2010","unstructured":"Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, Aukrust P, van Berkel TJ, Biessen EA: The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun. 2010, 394 (3): 792-797.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"710_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/CIRCGENETICS.110.957415","volume":"3","author":"MF Corsten","year":"2010","unstructured":"Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B: Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease. Circ Cardiovasc Genet. 2010, 3 (6): 499-506.","journal-title":"Circ Cardiovasc Genet"},{"issue":"6","key":"710_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/eurheartj\/ehq013","volume":"31","author":"GK Wang","year":"2010","unstructured":"Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q: Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010, 31 (6): 659-666.","journal-title":"Eur Heart J"},{"issue":"1","key":"710_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbrc.2010.12.119","volume":"405","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Kandic I, Kutryk MJ: Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochem Biophys Res Commun. 2011, 405 (1): 42-46.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"710_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1365-2362.2009.02110.x","volume":"39","author":"Y Minami","year":"2009","unstructured":"Minami Y, Satoh M, Maesawa C, Takahashi Y, Tabuchi T, Itoh T, Nakamura M: Effect of atorvastatin on microRNA 221 \/ 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest. 2009, 39 (5): 359-367.","journal-title":"Eur J Clin Invest"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-11-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T19:37:39Z","timestamp":1630611459000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-11-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-11-55","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,15]]},"assertion":[{"value":"21 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"55"}}